277 related articles for article (PubMed ID: 23334597)
21. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
22. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841
[TBL] [Abstract][Full Text] [Related]
23. A 3-month-delayed treatment with anatabine improves chronic outcomes in two different models of repetitive mild traumatic brain injury in hTau mice.
Morin A; Mouzon B; Ferguson S; Paris D; Saltiel N; Browning M; Mullan M; Crawford F
Sci Rep; 2021 Apr; 11(1):7900. PubMed ID: 33846461
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy.
Köhler C; Bista P; Götz J; Schröder H
Brain Res; 2010 Aug; 1347():111-24. PubMed ID: 20513372
[TBL] [Abstract][Full Text] [Related]
25. Modulation of tau pathology in tau transgenic models.
Brion JP; Ando K; Heraud C; Leroy K
Biochem Soc Trans; 2010 Aug; 38(4):996-1000. PubMed ID: 20658992
[TBL] [Abstract][Full Text] [Related]
26. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice.
Schultz MK; Gentzel R; Usenovic M; Gretzula C; Ware C; Parmentier-Batteur S; Schachter JB; Zariwala HA
Neurobiol Dis; 2018 Oct; 118():161-176. PubMed ID: 30049665
[TBL] [Abstract][Full Text] [Related]
27. Exclusive induction of tau2 epitope in microglia/macrophages in inflammatory lesions-tautwopathy distinct from degenerative tauopathies.
Uchihara T; Duyckaerts C; Seilhean D; Nakamura A; Lazarini F; Hauw JJ
Acta Neuropathol; 2005 Feb; 109(2):159-64. PubMed ID: 15549333
[TBL] [Abstract][Full Text] [Related]
28. Release of growth factors by neuronal precursor cells as a treatment for diseases with tau pathology.
Spillantini MG; Iovino M; Vuono R
Arch Ital Biol; 2011 Jun; 149(2):215-23. PubMed ID: 21701993
[TBL] [Abstract][Full Text] [Related]
29. Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds.
Castillo-Carranza DL; Gerson JE; Sengupta U; Guerrero-Muñoz MJ; Lasagna-Reeves CA; Kayed R
J Alzheimers Dis; 2014; 40 Suppl 1():S97-S111. PubMed ID: 24603946
[TBL] [Abstract][Full Text] [Related]
30. Beta-amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice.
Lomoio S; Scherini E; Necchi D
Brain Res; 2009 Nov; 1297():198-206. PubMed ID: 19703431
[TBL] [Abstract][Full Text] [Related]
31. Selective spatiotemporal patterns of glial activation and neuron loss in the sensory thalamocortical pathways of neuronal ceroid lipofuscinosis 8 mice.
Kuronen M; Lehesjoki AE; Jalanko A; Cooper JD; Kopra O
Neurobiol Dis; 2012 Sep; 47(3):444-57. PubMed ID: 22569358
[TBL] [Abstract][Full Text] [Related]
32. Repetitive Traumatic Brain Injury Causes Neuroinflammation before Tau Pathology in Adolescent P301S Mice.
Izzy S; Brown-Whalen A; Yahya T; Sarro-Schwartz A; Jin G; Chung JY; Lule S; Morsett LM; Alquraini A; Wu L; Hickman SE; Whalen MJ; El Khoury J
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477535
[TBL] [Abstract][Full Text] [Related]
33. Dietary supplementation with S-adenosyl methionine delayed amyloid-β and tau pathology in 3xTg-AD mice.
Lee S; Lemere CA; Frost JL; Shea TB
J Alzheimers Dis; 2012; 28(2):423-31. PubMed ID: 22045486
[TBL] [Abstract][Full Text] [Related]
34. Inhaled nitric oxide improves short term memory and reduces the inflammatory reaction in a mouse model of mild traumatic brain injury.
Liu P; Li YS; Quartermain D; Boutajangout A; Ji Y
Brain Res; 2013 Jul; 1522():67-75. PubMed ID: 23743262
[TBL] [Abstract][Full Text] [Related]
35. Repetitive head trauma, chronic traumatic encephalopathy and tau: Challenges in translating from mice to men.
Ojo JO; Mouzon BC; Crawford F
Exp Neurol; 2016 Jan; 275 Pt 3():389-404. PubMed ID: 26054886
[TBL] [Abstract][Full Text] [Related]
36. The relationship between glial distortion and neuronal changes following intestinal ischemia and reperfusion.
Thacker M; Rivera LR; Cho HJ; Furness JB
Neurogastroenterol Motil; 2011 Nov; 23(11):e500-9. PubMed ID: 21410600
[TBL] [Abstract][Full Text] [Related]
37. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model.
Ando K; Leroy K; Heraud C; Kabova A; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
Biochem Soc Trans; 2010 Aug; 38(4):1001-5. PubMed ID: 20658993
[TBL] [Abstract][Full Text] [Related]
38. Impact of nutrition on inflammation, tauopathy, and behavioral outcomes from chronic traumatic encephalopathy.
Yu J; Zhu H; Taheri S; Mondy W; Perry S; Kindy MS
J Neuroinflammation; 2018 Sep; 15(1):277. PubMed ID: 30249250
[TBL] [Abstract][Full Text] [Related]
39. Repression of tau hyperphosphorylation by chronic endurance exercise in aged transgenic mouse model of tauopathies.
Leem YH; Lim HJ; Shim SB; Cho JY; Kim BS; Han PL
J Neurosci Res; 2009 Aug; 87(11):2561-70. PubMed ID: 19360903
[TBL] [Abstract][Full Text] [Related]
40. Widespread neuronal and glial hyperphosphorylated tau deposition in ALS with cognitive impairment.
Yang W; Strong MJ
Amyotroph Lateral Scler; 2012 Feb; 13(2):178-93. PubMed ID: 22214313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
